In this study, a rAAV vector carrying a reporter gene,
Introduction
Gene transfer into the central nervous system (CNS) as a possible route for gene therapy of neurological diseases, either by in vivo or ex vivo methods, has gained attention in recent years (see reviews [1] [2] [3] [4] ). Among various gene delivery systems, viral vector-mediated gene transfer is considered to be the most efficient approach. Herpes simplex virus and adenovirus are both capable of infecting post-mitotic cells such as neurons and glial cells and have been used for gene transfer into the CNS. However, their applications in gene therapy have been associated with problems of immunogenicity and cytopathogenicity.
The adeno-associated virus (AAV) vector has gained increasing attention recently. Its nonpathogenicity and a wide host range make it a good candidate as a gene delivery system in the CNS. 5, 6 Adeno-associated virus is a small nonenveloped parvovirus. The wild-type AAV-2 genome contains a single-strand DNA of 4680 nucleotides. 7 It consists of one structural gene (cap) and one nonstructural gene (rep) responsible for the virus encapsidation and replication, respectively, and two inverted repeat sequences (ITRs) of 145 bases which are minimal essential cis-acting sequences required for virus replication, host integration, packaging, etc. So far, no human disease has been reported to be associated with AAV. Coinfection by helper viruses (eg adenovirus or herpes simplex virus) is required for productive AAV infections. Without helper viruses its genome integrates into host chromosome DNA, preferentially into the human chromosome 19. 8 Recombinant AAV vector is generated by removing the rep and cap genes and placing a 'transgene' between the ITRs.
The oligodendrocyte is the myelin-forming cell in the CNS. It plays a major role in function and maintenance of the myelin sheath. 9 Metabolic perturbation of oligodendrocytes resulting from genetic defects, toxins, infection, etc causes defective myelination and/or demyelination. The specific targeting of gene transfer and expression into the oligodendrocytes may facilitate understanding of the pathogenesis of demyelination as well as a possible gene therapy for demyelinating diseases. Genes transferred by rAAV carrying the cytomegalovirus (CMV) immediate-early promoter have been found to be expressed preferentially in neurons. 10 In this study, we explored the possibility of gene expression in oligodendrocytes mediated by rAAV, using the green fluorescent protein (GFP) 11, 12 as a reporter gene under the control of the myelin basic protein (MBP) transcriptional control region. 13 
Results

Construction of rAAV-MBP-GFP
To investigate cell-specific expression in oligodendrocytes mediated by rAAV, the myelin basic protein (MBP) transcriptional control region, 13 which has been found previously to direct MBP gene expression specifically in oligodendrocytes by transgenic mouse studies, was chosen to control the expression of the GFP gene selected as a reporter. The rAAV vector carrying the MBP transcriptional control region and GFP gene was constructed by replacing the CMV promoter in plasmid pTR-UF2 with 1.9 kb of the MBP transcriptional control region 13 ( Figure 1 ). To maintain a viral genome size with maximum packaging efficiency, the neo R cassette in the pTR-UF2 plasmid was retained, thus generating a 4.76 kb AAV cassette which is close to the size of wild-type AAV.
Recombinant AAV viruses
Recombinant AAV-MBP-GFP and rAAV-CMV-GFP virus particles were generated by transfection of 293 cells with rAAV plasmid and a helper plasmid providing the rep and cap genes in trans-and co-infection by helper adenovirus. Southern analysis of Hirt 14 extracted viral DNA after DpnI digestion confirmed the successful rescue and replication of the rAAV cassette by the presence of full length DpnI resistant viral DNA (data not shown). After isopycnic gradient centrifugation, purified rAAV stocks of up to 10 12 virus particles per milliliter based on dot blot analysis were produced. The infectious titer measured by the replication center assay on 293 cells (reflecting the number of virus particles containing intact ITRs and being able to enter the nucleus) was approximately 10 000-fold less than the particle units. The infectious titers of the virus stocks used in vitro were 3 × 10 7 infection units (IU) /ml for rAAV-CMV-GFP and 8 × 10 7 IU/ml for rAAV-MBP-GFP and residual adenovirus estimated to be 0.5 and 0.1% of rAAV IU, respectively. The replication center assay indicated that there was some wild-type AAV contamination (at the level of 10% rAAV IU for rAAV-CMV-GFP stocks and less than 1% for rAAV-MBP-GFP stocks). The in vitro data presented in this report were based on the studies with purified rAAV preparations without further heat inactivation. For in vivo studies, virus stocks containing approximately 8 × 10 7 IU/ml to 2 × 10 8 IU/ml were subjected to heat inactivation (30 min at 56°C). After heat inactivation no detectable adenovirus (less than 1 × 10 3 p.f.u./ml) was found by plaque assay. The level of wild-type AAV was less than 1% of rAAV IU in these stocks.
Transduction of oligodendrocyte cell line and primary cultures MOCH-1 is a transformed oligodendrocyte cell line. 15 Under 1% FBS conditions, the cells display an oligodendrocyte-like morphology and express MBP and other myelin-specific proteins. Transduction of MOCH-1 cells by rAAV-MBP-GFP produced GFP protein as early as 24 h after infection as demonstrated by the natural GFP green fluorescence. Approximately 5, 10 and 30% of cells expressed GFP at 2 days after infection at a multiplicity of infection (MOI) of 2.5, 5 and 7.5, respectively. The GFP fluorescence was located in the cytoplasm and nucleus, as well as the processes of MOCH-1 cells ( Figure 2 ) and was detectable for at least 3 weeks. To evaluate transduction on primary oligodendrocyte cultures, oligodendrocyte progenitor cells were purified from primary rat glial cells and allowed to differentiate to mature oligodendrocytes in the supplemented DMEM/F12 medium. The oligodendrocytes were identified by morphology and immunostaining with anti-O1 antibody. Between 30 and 50% of cells, after 4 days in the supplemented DMEM/F12 medium, were immunostained by anti-O1 antibody (data not shown). The number of mature oligodendrocytes with myelin sheath (immunostained with antibodies against MBP) increased gradually and reached maximum level (50-60%) at approximately day 10. The remaining cells mostly appeared to be type 1 astrocytes with some type 2 astrocytes.
Primary cultures of oligodendrocytes were infected with rAAV-MBP-GFP viruses between 5 and 11 days after initial plating. The GFP fluorescence was observed at 2 to 3 days after infection at a MOI of 10 based on the infectious units. The number of GFP-expressing cells reached a maximal level (approximately 35%) at 5-8 days after infection and remained relatively stable for another 2 weeks. The fluorescence was observed in both the cell bodies and the fine processes, but was weak ( Figure 3) . To determine the GFP-expressing cell types, cells were fixed and double-immunostained with anti-GFP antibody and anti-O1 antibody. Immunostaining with anti-GFP antibody resulted in stronger and more stable fluorescence. Double-immunostaining confirmed that the GFP-expressing cells transduced with rAAV-MBP-GFP were almost exclusively oligodendrocytes, as demonstrated by typical oligodendrocyte morphology and anti-O1 immunostaining (Figure 4 ). There were some GFPpositive/O1-negative cells which displayed small cell bodies bearing a few coarse processes, probably representing type 2 astrocytes. 16 No polygonal cells (typical type 1 astrocytes) were found expressing GFP. In contrast, parallel studies with rAAV-CMV-GFP resulted in stronger GFP-expressing in cells with different morphologies ( Figure 5 ): stellate cells with a few coarse radial processes and with negative anti-O1 immunostaining; and polygonal cells with a large cell body and negative anti-O1 immunostaining. Although some cells with multiple processes and with anti-O1 immunostaining also expressed the GFP, the anti-O1-negative types comprised approximately 90% of cells with GFP immunofluorescence.
To examine whether expression of GFP with rAAV-
Figure 2 Green fluorescent protein expression in the MOCH-1 cells transduced with rAAV. (a) A MOCH-1 cell displaying a native GFP fluorescence at 3 days after infection with rAAV-MBP-GFP. (b) The same field as (a) under phase contrast. Photographs were taken under an Olympus IMT2 inverted light microscope with a FITC filter. (c-f) MOCH-1 cells were infected with increasing amounts (MOI = 0, MOI = 2.5, MOI = 5 and MOI = 7.5 in c, d, e and f, respectively) of rAAV-MBP-GFP and examined under Nikon microphoto FXA light microscope 2 days after infection.
MBP-GFP transduction was restricted to oligodendrocytes, the 293 cells and primary cultures of astrocytes were infected by rAAV-MBP-GFP viruses at an MOI of 10. The GFP expression was observed in 293 cells and a few type-2-like astrocytes in the primary culture of astrocytes. We do not know why the MBP promoter in the rAAV infection showed relatively high expression in 293 cells. However, it remains a possibility that amplification of rAAV by contaminating adenovirus and a wild-type AAV could have contributed to the high transduction in this cell type.
Transfection of cell cultures with plasmid constructs
In order to show that the relative activity of each promoter was an intrinsic property of the construct and not due to contaminating adenovirus or a wild-type AAV, we assayed the promoter-reporter constructs by transfection of 293 cells, HeLa cells, and primary cultures of astrocytes and oligodendrocytes with pTR-UF2 plasmid (the CMV-GFP construct) and pTR-MBP-GFP plasmid. Forty-eight hours after transfection with the CMV-GFP construct, the GFP was expressed in more than 60% of 293 or HeLa cells. Approximately 35% of cells in the primary culture of astrocytes expressed the GFP driven by the CMV promoter, suggesting that the CMV promoter was active in this cell type in vitro. Less than 5% of cells in the primary cultures of oligodendrocytes expressed GFP after transfection with the CMV-GFP construct and appeared to be all large polygonal astrocytes which typically constituted a small percentage and increased 
Figure 4 Double-immunostaining of rAAV-MBP-GFP transduced oligodendrocytes with anti-GFP and anti-O1 antibodies. Primary cultures of oligodendrocytes (in defined DMEM-F12 medium for 10 days) were infected with rAAV-MBP-GFP at an MOI of 10. Cells were fixed at 3 weeks after infection and double-immunostained with anti-GFP and anti-O1 antibodies as described in the text. The GFP and O1 immunofluorescence was observed under a FITC filter (a) and a TRITC filter (b), respectively. Several oligodendrocytes including the processes were stained with anti-GFP antibody (a) and anti-O1 antibody (b). (c)
The phase contrast view of the same field. 
Primary cultures of oligodendrocytes (in defined DMEM-F12 medium for 10 days) were infected by rAAV-CMV-GFP at an MOI of 10. (a-f), Cells were fixed 3 weeks after infection, double-immunostained with anti-GFP polyclonal antibody and anti-O1 monoclonal antibody and observed with a FITC filter for GFP expression (a and d), a TRITC filter for O1 expression (c and f) and phase contrast (b and e). Green fluorescent protein immunofluorescence was observed in a polygonal cell (a) and a stellate cell with a few coarse processes (d). Neither cell was immunostained with anti-O1 antibodies (c and f). (g) Two polygonal cells on the edge of cell cultures displayed native GFP fluorescence at 12 days after infection. (h) The phase contrast view of g.
gradually in the primary culture of oligodendrocytes. Transfection with pTR-MBP-GFP plasmid resulted in the GFP expression in a few cells in both 293 cells and HeLa cells, indicating there was some 'leaking expression' in this cell type by the MBP promoter. Inconsistent with the transduction studies in vitro, no GFP fluorescence was observed in the primary cultures of astrocytes transfected with the pTR-MBP-GFP plasmid, suggesting that this promoter was silent or exhibited very low activity in this cell type. We did not detect any GFP fluorescence in the primary culture of oligodendrocytes, which was probably due to the low transfection efficiency in this cell type. Nevertheless, the data of astrocytes suggested that the pattern of expression in the transduction studies described above was attributed mainly to the intrinsic properties of the promoters. The CMV immediate-early promoter is one of the strongest constitutively active virus-derived transcription elements and has been used for high-level expression of a multitude of genes in many different cell types. In studies of virus-mediated gene transfer in CNS in vivo, however, gene expression under the control of the CMV promoter has often resulted in expression of the foreign gene primarily in neurons and has decreased over time. 6, 10, 17 The use of endogenous transcriptional control sequences may provide a distinct advantage in terms of stability of gene expression and cell-type specificity over viral transcriptional elements. Recently, Peel et al 18 demonstrated the efficient transduction of green fluorescent protein in neurons using neuron cell-type-specific promoter. However, whether rAAV can transfer genes into cells other than neurons in the brain remains to be tested. 
One microliter of rAAV-MBP-GFP virus was injected into the left hemisphere of the mouse brain. Tissue sections were double-immunostained with anti-GFP and anti-GFAP antibodies 15 days after injection. (a) GFPexpressing cells were labeled with FITC-conjugated antibody and detected only in the corpus callosum under a FITC filter. The arrowhead represents the needle injection site. C, cortex; CC, corpus callosum; LV, lateral ventricle; LS, lateral septal; solid arrow, fissure. Bar = 200 m. (b) A higher magnification view of the box region in (a) under a triple filter (FITC, TRITC and UV). GFP-expressing cells were labeled with FITC-conjugated antibody and GFAP-expressing cells were labeled with TRITC-conjugated antibody. The number of green fluorescence cells appearing in the photograph was lower than actually observed due to thick sections. No overlapping immunostaining between GFP and GFAP was observed. Bar = 30 m. (c) A different section examined under a FITC filter. Some fine processes (arrows) were also labeled with GFP immunofluorescence. Bar
Myelin basic protein is the second most abundant myelin protein both in the CNS and in the peripheral nervous system (PNS). The activity of the endogenous MBP transcriptional control region is limited to oligodendrocytes in the CNS and Schwann cells in the PNS. Previous studies have suggested that a 1.9 kb fragment of the MBP transcriptional control region was sufficient for appropriate spatial and temporal specificity in transgenic mice. 13 We therefore used this fragment to test the possibility of oligodendrocyte-specific expression mediated by rAAV. Due to the large size of the fragment of the control region and the limited capacity of rAAV, the relatively small 'humanized' green fluorescent protein 12 was chosen to be the reporter gene. The in vitro studies demonstrated that rAAV carrying the MBP promoter transduced oligodendrocytes preferentially over astrocytes, while the inverse was observed with rAAV using the CMV promoter to transcribe the identical reporter. Although the presence of adenovirus and wild-type AAV in some of our rAAV vector stocks used in in vitro studies might increase the transduction rates, parallel transfection studies suggested that it did not affect the cell-type-specific expression displayed by the promoters, especially in the primary glial cultures. Transfection of astrocytes with pTR-UF2 that carried the CMV promoter showed high GFP expression. In contrast, no GFP expression was observed in the astrocytes transfected with the construct carrying the MBP promoter. The lack of MBP-driven GFP expression in astrocytes was further supported by the in vivo studies. Infusion of rAAV-MBP-GFP virus that was heat treated to inactivate adenovirus, without a significant amount of wild-type AAV, into mouse brains resulted in the expression of GFP specifically in the white matter. These GFP-expressing cells generally contained oval shaped somata of 15-25 m and were arranged in parallel with each other and with the long axis of the nerve fibers. The processes that were immunostained with GFP appeared to be either radial processes near the cell somata or longitudinal processes which passed parallel along the long axis of the nerve fibers, resembling oligodendrocytes. 19, 20 Although various types of antibodies specific for different stages of oligodendrocytes were explored, their utility for the morphology studies of oligodendrocytes in the mature brains was very limited. 21 We could not observe the cell body staining with antibodies specifically against mature oligodendrocytes such as anti-MBP and antiCNPase antibodies due to the heavily myelin immunostaining in adult mice by these antibodies. Nevertheless, double-immunostaining with anti-GFP and anti-GFAP antibodies clearly showed that there was no overlapping immunostaining between anti-GFP and anti-GFAP antibodies in all tissue samples observed, which was consistent with the in vitro transfection and transduction results. Furthermore, the possibility of transduction of microglial cells by rAAV-MBP-GFP was ruled out since there was no overlapping immunostaining between anti-GFP and F4/80 antibodies. Cells located in the white matter are mainly oligodendrocytes, astrocytes and a small number of microglia and endothelial cells. Based on the results of double-immunostaining of anti-GFP antibody with anti-GFAP antibody and anti-GFP antibody with F4/80 antibody and the morphology of the GFP immunofluorescent cells, it is reasonable to suggest that the majority of GFPexpressing cells, if not all, were oligodendrocytes.
In conclusion, we believe that gene transfer mediated by rAAV is efficient in a variety of cell types including oligodendrocytes. However, the transduction efficiency observed in specific cell types was greatly influenced by the transcriptional control regions used to transcribe the reporter gene. Our results indicate that previous observations of neuron-dominated expression of rAAV vectors under the control of the CMV promoter 6,10 may be attributable to the relatively low level of activity of this promoter in glial cells, including oligodendrocytes in vivo, rather than a host range restriction of rAAV vectors. Cells other than neurons in the CNS can be efficiently transduced using the cell-type-specific transcriptional control region. This vector system may be useful for studies of gene therapy of demyelinating diseases as well as for neurobiological studies of myelin-forming cells.
Materials and methods
Cell cultures
All cell cultures were incubated at 37°C in a 5% CO 2 atmosphere. An adenovirus transformed human embryonic kidney cell line (293 cells) was maintained in Dulbecco's modified Eagle's medium (DMEM-H) supplemented with 10% fetal bovine serum (FBS), penicillin (100 IU/ml) and streptomycin (100 g/ml) (P/S). An oligodendrocyte cell line (MOCH-1 cells) 14 (provided by Dr B Popko, Neuroscience Center, University of North Carolina at Chapel Hill, NC, USA) was cultured in DMEM-H medium supplemented with 1% FBS and P/S. Primary rat glial cultures were maintained in Earle's basal medium (BME) supplemented with glutamine, 0.6% glucose, 10% FBS and P/S. Purified oligodendrocytes were maintained in DMEM/F12 medium supplemented with 0.5% FBS, bovine serum albumin (1.0 mg/ml), biotin (10 ng/ml), progesterone (20 nm), insulin (5 g/ml), putrescine (100 m), sodium bicarbonate (3.6 g/l), selenium (5 ng/ml), transferrin (50 g/ml), triiodothyronine (30 nm) and P/S.
Preparation of primary cultures of oligodendrocytes
Primary rat glial cultures were prepared from cerebral cortices of 1-to 3-day-old normal rat pups as described by McCarthy and de Vellis. 22 After 7-10 days in vitro, oligodendrocyte progenitor cells were separated from the confluent astrocyte bed by the shaking method of McCarthy and de Vellis. 23 Cells were suspended in supplemented BME medium and seeded on to coverslips precoated with 100 g/ml of poly-d-lysine (Sigma Chemical, St Louis, MO, USA) at a density of 4-5 × 10 4 /cm 2 . On the next day, cells were fed with supplemented DMEM/F12 medium and then were fed every 2-3 days thereafter. The astrocytes were maintained in the supplemented BME medium.
Plasmid constructions
The construct of pTR-MBP-GFP plasmid is depicted in Figure 1 . Briefly, a 1.9-kb fragment of MBP transcriptional control region 13 from the MBP/IFN-␥ construct of Corbin et al 24 was cleaved by SacI and XbaI digestions. Plasmid pTR-UF2 (Provided by Dr S Zolotukhin, Gene Therapy Center, University of Florida, USA) was treated by KpnI and XbaI digestions to remove the CMV transcriptional control region. Both the SacI site in the MBP/IFN-␥ construct and the KpnI site in the pTR-UF2 plasmid were converted to blunt-ends before ligation.
The excised fragment of 1.9-kb MBP transcriptional control region was gel purified by QiAquick gel extraction kit (Qiagene, Chatsworth, CA, USA) and subcloned into the pTR-UF2 plasmid. Plasmids pTR-MBP-GFP and pTR-UF2 were used to generate rAAV-MBP-GFP and rAAV-MBP-GFP viral vectors, respectively.
Generation of rAAV vectors
Recombinant AAV vectors were produced in 293 cells by calcium phosphate-mediated cotransfection of the vector plasmid with a complementing plasmid containing the AAV genes, rep and cap. 25 The cells were infected with adenovirus type 5 dl309 helper virus at a MOI of 5 at 16 h after transfection and harvested at 48 h after infection when full cytopathic effects were observed. The cells were harvested and lysed by three cycles of freeze-thaw. Virus was precipitated by (NH 4 ) 2 SO 4 . The precipitate was redissolved in 4.5 g/cm 3 CsCl followed by centrifugation at 288 000 g for 36 h in a SW41 rotor to band the recombinant virus at its buoyant density. The gradient was fractionated and each fraction assayed for rAAV by dot blot hybridization 26 or marker gene expression. Fractions containing virus were pooled, diluted with 4.5 g/cm 3 CsCl, and subjected to a second round of centrifugation at 400 000 g in an NVT 65 rotor for 4 h. The gradients were fractionated and assayed as above. The fraction containing the highest amount of virus particle was dialyzed against 20 mm Hepes containing 15% glycerol at 4°C. Aliquots were subjected to heat treatment at 56°C for 30 min to inactivate residual adenovirus. The level of residue adenovirus was determined by plaque assay. The virus titer was determined by the dot blot assay 27 or replication center assay 28 which was also used to determine the wildtype AAV level.
DNA hybridization
All DNA probes were labeled by the random priming method using the ready-to-go kit (Pharmacia Biotech, Piscataway, NJ, USA). Blots were hybridized overnight in a SSPE buffer solution containing 50% formaldehyde, 10% dextran sulfate (Sigma Chemical), 1% powder milk and 0.1% SDS at 42°C. All later steps were performed following the standard method. 26 Infection of cell cultures MOCH-I cells were seeded at 2 × 10 4 /cm 2 on a 12-mm coverslip or directly in 24-well plates. Next day, cells were infected by rAAV at a MOI of 10. Oligodendrocyteprogenitor cells were maintained in the supplemented DMEM/F12 medium and differentiated into mature oligodendrocytes. At 5-11 days after initial seeding, these primary cultures of oligodendrocytes were infected by aliquots of rAAV virus at a MOI of 10. After 1.5-4 h the cells were washed twice and maintained in the supplemented DMEM/F12 medium. At various time-points, living cells were examined directly under an Olympus IMT2 inverted light microscope (Olympus, Lake Success, NY, USA) with a FITC filter (450-500 nm excitation, 515 nm long path emission). To identify cell types, cells were fixed with 4% paraformaldehyde, then subjected to the following immunocytochemical studies.
Transfection of cell cultures
One day before transfection, 293 cells, HeLa cells and astrocytes, purified as above, were plated in six-well dishes at a density of 60-75%. Primary cultures of oligodendrocytes were prepared as described before. Three days after plating, the cultures of oligodendrocytes were used for the transfection studies. The transfection was carried out using SuperFect transfection kit (Qiagene) according to the manufacturer's instructions. Briefly, between 2 and 4 g of pTR-UF2 and pTR-MBP-GFP DNA were mixed with the SuperFect reagents. After 10 min the mixture was applied to the cells. Two hours later, cells were washed with medium and then fed with the appropriate medium. At 48 and 72 h after transfection cells were observed for GFP fluorescence under an inverted microscope with a FITC filter.
Animals and microinjection C57BL/6 mice, female or male, 20 to 25 days old were used in this study. Mice were bred within the animal colony. All animal surgical and care procedures were approved by the Institutional Animal Care and Use Committee at the university. The microinjection procedures were based on the technique described by McCown et al. 10 In brief, the mice were anesthetized with 2.5 % of avertin (0.014 ml per gram of body weight). The skin over the skull was incised. The injection sites were determined based on the coordinates of sagittal suture and bregma. A small hole was drilled in the skull with a 26-gauge needle. The injector was lowered to a depth of 1.5 mm. Recombinant AAV-MBP-GFP virus of 1 l and a trace of Indian ink were co-injected into the brains over 5 min. The injector was left in place for 3 min. The incision was then sutured. The operated mice were either returned to the mother cage after they regained consciousness or to separate cages. For controls, the same volume of dialysis buffer with a trace of the ink was substituted for the rAAV.
Immunohistochemistry and immunocytochemistry
Fifteen days after injection, the animals were anesthetized and perfused with 4% paraformaldehyde for 10 min. Six hours after fixation, the brains were removed and transferred to PBS solution containing 20% sucrose and stored at 4°C overnight. Tissue sections were cut 40-50 m thick with a vibratome and mounted on probe-on slides (Fisher Scientific, Pittsburgh, PA, USA). Following 5 min immersion into PBS containing 50 mm ammonium chloride to quench free aldehyde group, the tissue sections were blocked for 1.5 h in PBS containing 10% normal goat serum, 0.2% of Triton X100. After blocking, sections were exposed to primary antibodies, either single-immunostained with polyclonal antibody against GFP (Clontech, Palo Alto, CA, USA) (1:150, diluted in PBS containing 5% normal goat serum/1% BSA) overnight at 4°C or doubleimmunostained with various combinations, including anti-GFP antibody with anti-GFAP monoclonal antibody (1:450, Sigma Chemical); anti-GFP antibody with F4/80 rat antibody (1:100, Serotec, Washington DC, USA). After extensive washing in PBS containing 0.2% Triton X100, tissue sections were exposed to FITC-conjugated goat anti-rabbit IgG (1:50, Sigma Chemical) only or with rhodamine (TRITC)-conjugated goat anti-mouse IgG or TRITC-conjugated goat anti-rat IgG (1:100, Cappel, Durham, NC, USA). No cross-reactions in the doubleimmunostained sections were found by the single immunostaining of anti-GFP antibody with anti-mouse or anti-rat goat IgG and anti-GFAP antibody or F4/80 antibody with anti-rabbit goat IgG.
MOCH-1 cells and oligodendrocytes in the primary cultures were identified by anti-O1 monoclonal antibody (1:10, Boehringer Mannheim, Indianapolis, IN, USA). Astrocytes were identified with polyclonal antibody against GFAP (1:150; Dako, Carpinteria, CA, USA). Double-immunostaining with anti-GFP and anti-GFAP antibodies or anti-GFP and anti-O1 antibodies was carried out sequentially.
After immunostaining, slides were coverslipped with anti-photobleaching mounting medium (0. 25% DABCO, 2% n-propyl gallate in polyvinyl alcohol/glycerol) and examined under either a Nikon microphoto FXA microscope (Nikon, Garden City, NJ, USA) equipped with an FITC filter, TRITC filter, and a FITC-TRITC-UV triple filter or confocal microscope equipped with a Zeiss microscope (Carl Zeiss, Thornwood, NY, USA).
